Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Erowid References Database
Larson AA, Chinn C, Proudfit HK, Anderson EG. 
“Dual Actions of Lysergic Acid Diethylamide Tartrate (LSD), 2-Bromo-D-Lysergic Acid Diethylamide Bitartrate (BOL) and Methysergide on Dorsal Root Potentials Evoked by Stimulation of Raphe Nuclei”. 
The Journal of Pharmacology and Experimental Therapeutics. 1981;217(1):99-104.
A variety of drugs reported to antagonize serotonin were found to affect spinal cord potentials evoked by electrical stimulation of the caudal raphe nuclei of the cat. These brain stem-evoked dorsal root potentials (DRPs) consisted of a short latency depolarization (DRP-1), which was evoked by stimulation of a wide variety of sites in the medial brain stem and a long latency potential (DRP-2), which was elicited only when stimuli were applied near the raphe. The ability of serotonergic antagonists to increase or decrease these DRPs was dependent on the dose of the drug administered. High doses of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamine bitartrate (BOL), methysergide and cinanserin each produced an immediate inhibition of DRP-2 and a simultaneous enhancement of DRP-1, both of which recoverd by approximately 30 min. Each of the drugs proudced a dose-related inhibition of DRP-2 at high doses, with LSD being the most potent and cinanserin the least potent. In contrast, low doses of LSD, BOL and methysergide elicited little or no immediate change in either DRP-2 or DRP-1, but produced an enhancement of DRP-2 which developed slowly over a period of 60 to 90 min. This increase in DRP-2 was most dramatic after administration of LSD and was not accompanied by changes in DRP-1. The inhibition of DRP-2 by high doses of LSD, BOL, methysergide and cinansering may result primarily from inhibition of postsynaptic serotonergic receptors located on the primary afferent terminals. The increase in DRP-2 produced by low doses of LSD, BOL and methysergide is postulated to result from an interaction with receptors distinct from those which produced the inhibition of DRP-2 at higher doses.
Comments and Responses to this Article
Submit Comment
[ Cite HTML ]